For 25 years, Extended Stability for Parenteral Drugs has been the trusted resource for reliable stability data beyond 24 hours on infusion products. Since the first edition in 2001, pharmacists and compounding teams in any setting where parenteral drugs are stored or compounded have relied on it to make confident, evidence-based decisions.
The 8th edition builds on the previous edition with a targeted review of new evidence and practice considerations that have emerged since its publication. It now includes 9 new monographs with 85 being completely updated for a total of 202 drug monographs.
What's Inside the 8th Edition
- 9 new monographs: Acetylcysteine, Carfilzomib, Cefiderocol, Ceftazidime-Avibactam, Ceftobiprole, Eculizumab, Nivolumab, Rezafungin, and Sodium Citrate
- 85 updated monographs incorporating the latest peer-reviewed stability studies and/or elastomeric device data, including stability data from 44 recently published studies
- Expanded guidance on closed-system transfer devices (CSTDs): an added section and information table address CSTDs and the risks they pose to drug stability
- Deeper discussion of uncertainty in extrapolation to help you apply stability data with greater confidence
- Added parenteral nutrition tables: cover macronutrient concentrations, the specific products studied, and IV lipid emulsion stability in various macronutrient combinations
Whether you are compounding in a hospital pharmacy, health system, or other sterile compounding setting, the 8th edition delivers the current, practical stability data you need to support safe, effective patient care.
“This is considered to be the foundation book for extended stability.”
(Lawrence P Carey, BS, PharmD)